Navigation Links
Hanger Reports First Quarter 2013 Results
Date:5/1/2013

n, Hanger's vision is to be the partner of choice for products and services that enhance human physical capability.  For more information on Hanger, visit www.hanger.com and follow us at www.Facebook.com/HangerNews, www.Twitter.com/HangerNews, and www.YouTube.com/HangerNews

This document contains forward-looking statements relating to the Company's results of operations.  The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements.  Statements relating to future results of operations in this document reflect the current views of management.  However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company's ability to enter into and derive benefits from managed care contracts, the demand for the Company's orthotic and prosthetic services and products and the other factors identified in the Company's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934.  The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

 Hanger, Inc.(in thousands, except for share and per share amounts)(Unaudited)Three Months EndedMarch, 31Income Statement:20132012Net sales

$
233,535$
218,091Material costs

67,73966,697Personnel costs

89,95381,153Other operating expenses

43,76940,144Acquisition expenses

7375Depreciation and amortization

9,2858,285Income from operations

22,71621,737Interest expense'/>"/>

SOURCE Hanger, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
2. Hanger Files Form 10-K for Year Ended December 31, 2012
3. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
4. Hanger, Inc. Has Record Year In O&P Acquisitions:
5. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
6. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
7. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
8. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
9. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
10. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
11. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... LA JOLLA, Calif. , Oct. 22, ... RGLS ), a biopharmaceutical company leading ... targeting microRNAs, today announced that it has ... from an ongoing clinical study evaluating RG-101, ... for the treatment of hepatitis C virus ...
(Date:10/20/2014)...  PneumRx, Inc. ( www.pneumrx.com ), a leader in ... enrollment in their RENEW Study, nearly 3 months ahead ... IDE pivotal trial for the PneumRx RePneu Coil System, ... anticipated that the study, which began enrolling subjects in ... end of 2014 to enroll 315 patients.  Instead, enrollment ...
(Date:10/20/2014)... 2014  Indianapolis interventional medical device maker ... -based 3D visualization leader Synaptive Medical ... Annual Meeting that they have joined forces to ... collaboration is the first of its kind and ... outcomes. NICO,s BrainPath® interventional access technology and Synaptive,s ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... OAKS, Calif., Sept. 8, 2011 Amgen (NASDAQ: ... Conference on Tuesday, Sept. 13, 2011 at the Grand Hyatt ...  Jim Daly, senior vice president of North America Commercial Operations ... be accessed from the Events Calendar on Amgen,s website, ...
... 2011 Positive results from the initial Phase 1 clinical ... the Sanaria® PfSPZ Vaccine are published today in the online ... "This is the first indication that a highly effective ... eliminate Plasmodium falciparum malaria in geographically defined areas ...
Cached Medicine Technology:Initial Trial of Sanaria's Malaria Vaccine Yields Positive Results 2Initial Trial of Sanaria's Malaria Vaccine Yields Positive Results 3Initial Trial of Sanaria's Malaria Vaccine Yields Positive Results 4
(Date:10/22/2014)... The United States is now mandating that all ... Africa land at one of five airports equipped ... In a statement released Tuesday, Homeland Security ... air passengers from Guinea, Liberia and Sierra Leone ... -- New York City,s Kennedy International Airport, Washington ...
(Date:10/22/2014)... October 22, 2014 The ... which is dedicated to distribute health information technology ... delivery worldwide announced the development of six key ... expect when receiving healthcare. These are an expansion ... care: “providing care that is respectful of and ...
(Date:10/22/2014)... Washington, D.C. (PRWEB) October 22, 2014 With ... November, a national survey by the American Institutes for Research ... they know how to use health insurance, but 42 percent ... review a plan’s details before signing up for coverage. , ... literacy, with only 20 percent able to calculate correctly how ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Best Cheap ... in the world. The site has recently announced that ... hosting supplier for people from around the world. , ... in operation today and is providing various kinds of ... the company insists on offering excellent customer service and ...
(Date:10/22/2014)... October 22, 2014 Losing Weight Your Body’s ... is staring you in the face, it certainly can be ... do your body an extra favor by doing it the ... crash diets. Instead, listen to your body, exercise regularly, and ... is essential to losing weight; you need to exercise more ...
Breaking Medicine News(10 mins):Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2
... /PRNewswire/ - Apotex today issued the following statement concerning an ... , , The Import Alert recently posted by FDA ... This alert relates to observations made following routine audits for ... with the FDA to resolve the identified concerns as quickly ...
... , , THOUSAND OAKS, Calif., ... in the Thomas Weisel Healthcare Conference on Friday, Sept. 11, 2009, ... Eastern Time. Roy Baynes, M.D. Ph.D., vice president of Global ... the presentation will be available over the Internet and can be ...
... , , HOPKINTON, Mass., Sept. ... today announced that Kevin Hrusovsky, President and CEO, will present at ... Tuesday, September 22, 2009 at 11:00 a.m. EDT. , ... be accessed at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=102_OHYDDUN . The replay of ...
... , Expanding facility will provide training for health ... area of the Bronx , , BRONX, N.Y., ... the newest addition to the non-profit agency on September 10, 2009 ... at the facility. Located at 1438 Ogden Ave., over 9,000 ...
... risk factors early on, researchers say , TUESDAY, Sept. 8 ... people with cystic fibrosis greatly increases their chances of developing ... an inherited disorder that can lead to deadly lung infections ... of the 30,000 people in the United States with the ...
... Combined efforts mean even stronger support for blood safety ... , WASHINGTON, Sept. 8 Safe Blood for Africa ... agreement to provide even stronger support for blood safety and donor programs ... diligently to support blood safety and blood donor programs throughout Africa. Hema-Quebec ...
Cached Medicine News:Health News:Amgen to Present at the Thomas Weisel Healthcare Conference 2Health News:Highbridge Community Life Center Grand Opening and Ribbon Cutting Ceremony for New Health Careers/Education Facility in the Bronx 2Health News:Gene Linked to Liver Disease in Cystic Fibrosis 2Health News:Safe Blood for Africa Foundation and Hema-Quebec Sign Far-Reaching Agreement 2
The double beveled oblique blade provides a true, straight incision. Penetrating through Bowman's and Descemet's membranes without inducing corneal distortion. No need to "Dimple Down"....
... The Boomerang ClosureWire Vascular Closure System ... Arteriotomy Site-Specific Compression., ,The Boomerang ClosureWire ... the inside of the arteriotomy and ... in a targeted internal compression of ...
... The new hand-held Slit Lamp HSL150 with ... filter For Human and Veterinary medicine for ... With an ergonomic, compact,design, the new HEINE ... a,standard slit lamp is not available,or practical ...
... Geriatrics At Your Fingertips ... geriatrics that provides up-to-date, practical information on ... disorders most common to elderly people. Updated ... the GAYF web site, where versions for ...
Medicine Products: